SCHEMBL7298552

SCHEMBL7298552

Cc1cccc(COC(=O)N[C@H](C(=O)O)C(C)C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.46
PDE5A O76074 1/20 0.42
ECE1 P42892 2/20 0.42
MME P08473 2/20 0.42
MEN1 O00255 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
KMT2A Q03164 1/20 0.41
CTSL P07711 2/20 0.41
CTSB P07858 2/20 0.41
CTSK P43235 2/20 0.41
CTSS P25774 1/20 0.41
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
ADAMTS4 O75173 2/20 0.40
MMP13 P45452 1/20 0.39
ELANE P08246 2/20 0.39
ATM Q13315 1/20 0.39
GRM5 P41594 1/20 0.39
GRM1 Q13255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303071 1.00 TYR (0.46) TYRPDE5AECE1MMEMEN1
SCHEMBL7307873 0.90 MEN1 (0.41) TYRMEN1OPRM1OPRD1KMT2A
SCHEMBL3033874 0.81 NPC1 (0.59) TYRECE1MMECTSLCTSB
SCHEMBL4675990 0.81 NPC1 (0.59) TYRECE1MMECTSLCTSB
SCHEMBL7307096 0.80 ADAMTS4 (0.55) ADAMTS4
SCHEMBL7298298 0.80 ADAMTS4 (0.55) ADAMTS4
SCHEMBL6445922 0.80 NPC1 (0.58) TYRECE1MMECTSLCTSB
SCHEMBL6445930 0.80 NPC1 (0.58) TYRECE1MMECTSLCTSB
SCHEMBL7304100 0.79 CYSLTR2 (0.43) TYRPDE5AECE1MMECTSL
SCHEMBL7308154 0.78 CYP3A4 (0.46) ECE1MMECTSBCTSKCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed